Edyta Paradowska (E Paradowska)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Current oncology (Toronto, Ont.)

Cancers

Biomedicines

Institute of Medical Biology, Polish Academy of Sciences

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Medical Biology, Polish Academy of Sciences Jan 01 2004

Poland

Professor :: Laboratory of Virology

Education History

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

Poland

PHD

University of Wrocław

Poland

MSC

Publications

Dariusz Jarych, Damian Mikulski, Milosz Wilczynski, Magdalena Zgliczynska, Katarzyna Dominika Kania, Daria Haręża, Andrzej Malinowski, Ewelina Perdas, Mateusz Nowak, Edyta Paradowska
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms. International journal of molecular sciences 25 (2) (2024)
Magdalena Zgliczynska, Edyta Paradowska, Milosz Wilczynski
High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. Biomedicines 12 (1) (2024)
Magdalena Zgliczynska, Edyta Paradowska, Milosz Wilczynski
High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. Biomedicines 12 (1) (2024)
Dariusz Jarych, Damian Mikulski, Milosz Wilczynski, Magdalena Zgliczynska, Katarzyna Dominika Kania, Daria Haręża, Andrzej Malinowski, Ewelina Perdas, Mateusz Nowak, Edyta Paradowska
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms. International journal of molecular sciences 25 (2) (2024)
Dariusz Jarych, Damian Mikulski, Milosz Wilczynski, Magdalena Zgliczynska, Katarzyna Dominika Kania, Daria Haręża, Andrzej Malinowski, Ewelina Perdas, Mateusz Nowak, Edyta Paradowska
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms. International journal of molecular sciences 25 (2) (2024)
Magdalena Zgliczynska, Edyta Paradowska, Justyna Wilczyńska, Miłosz Wilczyński
Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. Current oncology (Toronto, Ont.) 31 (1) (2023)
Magdalena Zgliczynska, Edyta Paradowska, Justyna Wilczyńska, Miłosz Wilczyński
Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. Current oncology (Toronto, Ont.) 31 (1) (2023)
Magdalena Zgliczynska, Edyta Paradowska, Justyna Wilczyńska, Miłosz Wilczyński
Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. Current oncology (Toronto, Ont.) 31 (1) (2023)
Magdalena Zgliczynska, Edyta Paradowska, Milosz Wilczynski
Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? Journal of personalized medicine 14 (1) (2023)
Magdalena Zgliczynska, Edyta Paradowska, Milosz Wilczynski
Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? Journal of personalized medicine 14 (1) (2023)
Magdalena Zgliczynska, Edyta Paradowska, Justyna Wilczyńska, Miłosz Wilczyński
Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. Current oncology (Toronto, Ont.) 31 (1) (2023)
Magdalena Zgliczynska, Milosz Wilczynski, Edyta Paradowska
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies. International journal of molecular sciences 23 (5) (2022)
Magdalena Zgliczynska, Maria Szubert, Edyta Paradowska, Miłosz Wilczyński
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). Cancers 15 (1) (2022)
Magdalena Zgliczynska, Maria Szubert, Edyta Paradowska, Miłosz Wilczyński
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). Cancers 15 (1) (2022)
Katarzyna Dominika Kania, Daria Haręża, Magdalena Zgliczynska, Milosz Wilczynski, Dariusz Jarych, Andrzej Malinowski, Edyta Paradowska
The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer. Cells 11 (19) (2022)
Daria A Haręża, Magdalena Zgliczynska, Edyta Paradowska
Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins. International journal of molecular sciences 23 (3) (2022)
Magdalena Zgliczynska, Maria Szubert, Edyta Paradowska, Miłosz Wilczyński
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). Cancers 15 (1) (2022)
Agnieszka Jabłońska, Elżbieta Jabłonowska, Mirosława Studzińska, Juliusz Kamerys, Edyta Paradowska
The TLR9 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients. Cells 10 (9) (2021)
Agnieszka Jabłońska, Branislav Zagrapan, Edyta Paradowska, Christoph Neumayer, Wolf Eilenberg, Christine Brostjan, Markus Klinger, Josif Nanobachvili, Ihor Huk
Abdominal aortic aneurysm and virus infection: A potential causative role for cytomegalovirus infection? Journal of medical virology 93 (8) (2021)
Waldemar Wagner, Katarzyna Sobierajska, Katarzyna Dominika Kania, Edyta Paradowska, Wojciech Michał Ciszewski
Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation. International journal of molecular sciences 22 (24) (2021)
Agnieszka Jabłońska, M Studzińska, P Suski, J Kalinka, Edyta Paradowska
Enhanced expression of IFI16 and RIG-I in human third-trimester placentas following HSV-1 infection. Clinical and experimental immunology 193 (2) (2019)

Edyta Paradowska.css-eqlu8i{font-size:small;padding-left:4px;} (E Paradowska)

Publication Activity (10 Years)

Top Topics

Top Venues

Edyta Paradowska (E Paradowska)